In order to correlate the clinical and pathological parameters with ADAM10 and ADAM17 expression, RB tumors were categorized into non-expressing, weakly expressing, expressing, and highly expressing ADAM10 and ADAM17 specimens. The gene discussed is ADAM17; the disease is retinoblastoma.